As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare
— U.S. FDA (@US_FDA) April 13, 2021
CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases.
— U.S. FDA (@US_FDA) April 13, 2021
Please join us via YouTube for an audio press conference at 10 a.m. EDT. We will keep the public updated as we learn more. *****fWguuQzhMR
— U.S. FDA (@US_FDA) April 13, 2021